Talon Private Wealth LLC Takes Position in Merit Medical Systems, Inc. $MMSI

Talon Private Wealth LLC bought a new position in Merit Medical Systems, Inc. (NASDAQ:MMSI) during the 1st quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The fund bought 8,597 shares of the medical instruments supplier’s stock, valued at approximately $593,000.

Several other institutional investors also recently bought and sold shares of the stock. Lido Advisors LLC boosted its holdings in shares of Merit Medical Systems by 3.8% during the 4th quarter. Lido Advisors LLC now owns 3,836 shares of the medical instruments supplier’s stock valued at $324,000 after purchasing an additional 140 shares during the last quarter. AMI Asset Management Corp lifted its position in shares of Merit Medical Systems by 0.8% in the first quarter. AMI Asset Management Corp now owns 21,818 shares of the medical instruments supplier’s stock worth $1,504,000 after buying an additional 168 shares in the last quarter. Maryland State Retirement & Pension System boosted its stake in Merit Medical Systems by 2.1% during the fourth quarter. Maryland State Retirement & Pension System now owns 8,693 shares of the medical instruments supplier’s stock valued at $766,000 after buying an additional 180 shares during the last quarter. Blue Trust Inc. grew its holdings in Merit Medical Systems by 11.0% during the 4th quarter. Blue Trust Inc. now owns 1,853 shares of the medical instruments supplier’s stock valued at $163,000 after buying an additional 184 shares in the last quarter. Finally, First Horizon Corp increased its stake in Merit Medical Systems by 19.7% in the 4th quarter. First Horizon Corp now owns 1,117 shares of the medical instruments supplier’s stock worth $98,000 after acquiring an additional 184 shares during the last quarter. 99.66% of the stock is owned by hedge funds and other institutional investors.

Wall Street Analyst Weigh In

A number of research firms have recently commented on MMSI. Compass Point set a $107.00 target price on Merit Medical Systems in a research report on Monday, April 20th. Wells Fargo & Company decreased their price target on shares of Merit Medical Systems from $78.00 to $74.00 and set an “equal weight” rating on the stock in a research note on Friday, May 1st. Barrington Research lowered their price objective on shares of Merit Medical Systems from $109.00 to $107.00 and set an “outperform” rating for the company in a research report on Monday, April 20th. Citigroup reissued an “outperform” rating on shares of Merit Medical Systems in a research note on Monday, April 20th. Finally, Robert W. Baird set a $83.00 target price on shares of Merit Medical Systems in a report on Friday, May 1st. Eight analysts have rated the stock with a Buy rating, two have given a Hold rating and one has assigned a Sell rating to the company. Based on data from MarketBeat, the stock currently has an average rating of “Moderate Buy” and a consensus price target of $92.80.

Insider Activity

In other Merit Medical Systems news, insider Brian G. Lloyd bought 2,000 shares of the company’s stock in a transaction on Thursday, May 7th. The stock was acquired at an average price of $62.62 per share, for a total transaction of $125,240.00. Following the completion of the transaction, the insider directly owned 2,000 shares of the company’s stock, valued at approximately $125,240. This represents a ∞ increase in their ownership of the stock. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available at the SEC website. Also, Director Lynne N. Ward sold 5,000 shares of the stock in a transaction that occurred on Thursday, May 7th. The stock was sold at an average price of $62.61, for a total value of $313,050.00. Following the completion of the sale, the director owned 7,809 shares in the company, valued at approximately $488,921.49. The trade was a 39.04% decrease in their ownership of the stock. Additional details regarding this sale are available in the official SEC disclosure. 0.70% of the stock is owned by company insiders.

Merit Medical Systems Trading Up 3.3%

MMSI stock opened at $80.84 on Thursday. Merit Medical Systems, Inc. has a twelve month low of $59.74 and a twelve month high of $94.75. The stock has a market capitalization of $4.82 billion, a price-to-earnings ratio of 35.00, a price-to-earnings-growth ratio of 2.44 and a beta of 0.52. The company has a quick ratio of 3.46, a current ratio of 5.08 and a debt-to-equity ratio of 0.45. The firm’s fifty day simple moving average is $69.06 and its two-hundred day simple moving average is $71.71.

Merit Medical Systems (NASDAQ:MMSI) last released its quarterly earnings results on Thursday, April 30th. The medical instruments supplier reported $0.94 EPS for the quarter, topping analysts’ consensus estimates of $0.84 by $0.10. The firm had revenue of $381.88 million during the quarter, compared to analysts’ expectations of $377.59 million. Merit Medical Systems had a net margin of 9.03% and a return on equity of 13.54%. The firm’s revenue for the quarter was up 7.4% compared to the same quarter last year. During the same period in the previous year, the company earned $0.86 EPS. As a group, analysts anticipate that Merit Medical Systems, Inc. will post 3.62 earnings per share for the current year.

About Merit Medical Systems

Merit Medical Systems, Inc is a global manufacturer and marketer of a broad range of medical devices used in diagnostic and interventional procedures. The company’s product portfolio encompasses vascular access, drainage, embolotherapy, and interventional oncology devices, as well as radiofrequency ablation systems and hemostasis solutions. These products serve physicians and hospitals in critical care settings and support minimally invasive treatment options across multiple specialties, including cardiology, radiology, oncology, neurology and endoscopy.

Founded in 1987 by Fred Lampropoulos, Merit Medical Systems has grown through both organic development and targeted acquisitions to expand its technology offerings and geographic reach.